172 related articles for article (PubMed ID: 2523646)
1. A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. Isradipine in Hypertension Study Group.
Am J Med; 1989 Apr; 86(4A):119-23. PubMed ID: 2523646
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension. The British Isradipine Hypertension Group.
Am J Med; 1989 Apr; 86(4A):110-4. PubMed ID: 2523644
[TBL] [Abstract][Full Text] [Related]
3. Multicenter evaluation of the safety and efficacy of isradipine in hypertension. The Italian-Belgian Isradipine Study Group.
Am J Med; 1989 Apr; 86(4A):94-7. PubMed ID: 2523664
[TBL] [Abstract][Full Text] [Related]
4. Additive effect of isradipine in combination with captopril in hypertensive patients.
Eggertsen R; Svensson A; Dahlöf B; Hansson L
Am J Med; 1989 Apr; 86(4A):124-6. PubMed ID: 2523647
[TBL] [Abstract][Full Text] [Related]
5. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
Frithz G; Aström B; Dahlöf B; Hansson L; Tollin C; Himanen P; Sundstedt CD
Am J Med; 1989 Apr; 86(4A):115-8. PubMed ID: 2523645
[TBL] [Abstract][Full Text] [Related]
6. A multicenter evaluation of the safety, tolerability, and efficacy of isradipine in the treatment of essential hypertension.
Sundstedt CD; Rüegg PC; Keller A; Waite R
Am J Med; 1989 Apr; 86(4A):98-102. PubMed ID: 2523665
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of isradipine and atenolol on peripheral hemodynamics and arterial compliance.
Jespersen LT; Krusell LR; Sihm I; Pedersen OL
Am J Med; 1989 Apr; 86(4A):57-9. PubMed ID: 2523656
[TBL] [Abstract][Full Text] [Related]
8. Dose-response relationship and incidence of adverse drug reactions with isradipine in patients with essential hypertension.
Simonsen K; Sundstedt CD
Am J Med; 1989 Apr; 86(4A):91-3. PubMed ID: 2523663
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of isradipine in hypertension.
Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
[TBL] [Abstract][Full Text] [Related]
10. Swedish Isradipine Study in Hypertension: evaluation of quality of life, safety, and efficacy. SWISH Group.
Jern S; Hansson L; Scherstén B; Kullman S; Sörensen S; Dahlöf B; Eggertsen R; Sivertsson R
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S7-8. PubMed ID: 1720487
[TBL] [Abstract][Full Text] [Related]
11. Multicenter comparison of once- and twice-daily isradipine to hydrochlorothiazide for the treatment of hypertension in elderly patients.
Holtzman JL; Abrams A; Cutler R; Hamilton B; Kirkendall WM; Neri G; Stein GH; Matthews KP
Clin Pharmacol Ther; 1990 Nov; 48(5):590-7. PubMed ID: 2146060
[TBL] [Abstract][Full Text] [Related]
12. Atenolol and chlorthalidone therapy for hypertension: a double-blind comparison.
Curry RC; Schwartz KM; Urban PL
South Med J; 1988 Nov; 81(11):1401-6, 1411. PubMed ID: 3055324
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive effects of isradipine and captopril as monotherapy or in combination.
Fitscha P; Meisner W; Hitzenberger G
Am J Hypertens; 1991 Feb; 4(2 Pt 2):151S-153S. PubMed ID: 1827007
[TBL] [Abstract][Full Text] [Related]
14. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic response, safety, and efficacy of isradipine in the treatment of essential hypertension.
Dahlöf B
Am J Med; 1989 Apr; 86(4A):19-26. PubMed ID: 2523651
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension.
Winer N; Thys-Jacobs S; Kumar R; Davidson WD; Grayson M; Harris C; Walker D; Itskovitz H; Gonasun L
Clin Pharmacol Ther; 1987 Oct; 42(4):442-8. PubMed ID: 2959426
[TBL] [Abstract][Full Text] [Related]
17. Isradipine in essential hypertension: the Belgian General Practitioners' Study.
De Keyser P; Bouvé J; Clement D; Degraef R; Meurant JP; Rorive G; Van Thillo J
Am J Med; 1989 Apr; 86(4A):103-9. PubMed ID: 2565687
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
Kirch W; Burger KJ; Weidinger G; Welzel D
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
[TBL] [Abstract][Full Text] [Related]
19. Placebo-controlled trial of once-a-day isradipine monotherapy in mild to moderately severe hypertension.
Winer N; Kirkendall WM; Canosa FL; Lewin AJ; McMahon FG; Carr AA; Cohen M
J Clin Pharmacol; 1990 Nov; 30(11):1006-11. PubMed ID: 2147029
[TBL] [Abstract][Full Text] [Related]
20. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
Welzel D; Burger KJ; Weidinger G
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
